• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

irritable bowel syndrome (IBS) - Articles and news items


First patients dosed in Bekinda IBS-D trial

Industry news / 22 June 2016 / Victoria White, Digital Content Producer

The first patients have been dosed in a Phase II clinical study with RedHill Biopharma’s Bekinda 12 mg for diarrhoea-predominant irritable bowel syndrome…


Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionFIND OUT MORE
+ +